![]() | 1 | MERRIMACK PHARMACEUTICALS INC |  | 2919.74% | 230.0 |  |
 | 2 | CORCEPT THERAPEUTICS INC |  | 587.07% | 19.0 |  |
 | 3 | CONCERT PHARMACEUTICALS INC. |  | 532.39% | 156.0 |  |
 | 4 | Sonoma Pharmaceuticals Inc. |  | 415.28% | 201.0 |  |
 | 5 | OPIANT PHARMACEUTICALS INC. |  | 364.38% | 277.0 |  |
![]() | 6 | BIOSPECIFICS TECHNOLOGIES CORP |  | 327.05% | -1.0 |  |
![]() | 7 | IVERIC bio Inc. |  | 323.18% | 0.0 |  |
 | 8 | EAGLE PHARMACEUTICALS INC. |  | 287.32% | -6.0 |  |
![]() | 9 | SPRING PHARMACEUTICAL GROUP INC. |  | 284.62% | -3.0 |  |
 | 10 | Jazz Pharmaceuticals plc |  | 282.47% | 0.0 |  |
 | 11 | Avalo Therapeutics Inc. |  | 270.04% | 0.0 |  |
 | 12 | ENANTA PHARMACEUTICALS INC |  | 229.51% | -3.0 |  |
![]() | 13 | CAMBREX CORP |  | 226.98% | 2.0 |  |
 | 14 | UNITED THERAPEUTICS Corp |  | 221.24% | -10.0 |  |
 | 15 | MEI Pharma Inc. |  | 220.45% | 0.0 |  |
![]() | 16 | XYNOMIC PHARMACEUTICALS HOLDINGS INC. |  | 218.90% | 0.0 |  |
 | 17 | Emergent BioSolutions Inc. |  | 218.26% | 14.0 |  |
![]() | 18 | Bioverativ Inc. |  | 207.56% | 0.0 |  |
 | 19 | REGENERON PHARMACEUTICALS INC. |  | 204.70% | -1.0 |  |
 | 20 | Catalent Inc. |  | 189.26% | -4.0 |  |
 | 21 | AbbVie Inc. |  | 184.90% | -10.0 |  |
 | 22 | ABBOTT LABORATORIES |  | 183.52% | -8.0 |  |
 | 23 | SUPERNUS PHARMACEUTICALS INC. |  | 180.78% | -16.0 |  |
![]() | 24 | TENAX THERAPEUTICS INC. |  | 179.18% | 9.0 |  |
 | 25 | AVADEL PHARMACEUTICALS PLC |  | 176.70% | 75.0 |  |
 | 26 | China Health Industries Holdings Inc. |  | 171.56% | 1.0 |  |
![]() | 27 | Cocrystal Pharma Inc. |  | 165.08% | 0.0 |  |
 | 28 | Merck & Co. Inc. |  | 162.64% | -9.0 |  |
 | 29 | PROCYON CORP |  | 161.82% | 0.0 |  |
 | 30 | XOMA Corp |  | 156.09% | 216.0 |  |
 | 31 | Aptevo Therapeutics Inc. |  | 155.82% | 0.0 |  |
 | 32 | Amphastar Pharmaceuticals Inc. |  | 137.98% | -6.0 |  |
 | 33 | SEELOS THERAPEUTICS INC. |  | 135.19% | 204.0 |  |
 | 34 | ANAPTYSBIO INC |  | 130.35% | 0.0 |  |
![]() | 35 | ALEXION PHARMACEUTICALS INC. |  | 124.66% | -1.0 |  |
 | 36 | PFIZER INC |  | 124.23% | 0.0 |  |
 | 37 | LANDEC CORP \CA\ |  | 120.65% | 9.0 |  |
 | 38 | ALPINE IMMUNE SCIENCES INC. |  | 120.38% | 123.0 |  |
 | 39 | VERTEX PHARMACEUTICALS INC MA |  | 114.90% | 14.0 |  |
 | 40 | MACROGENICS INC |  | 111.24% | 22.0 |  |
 | 41 | LIGAND PHARMACEUTICALS INC |  | 110.67% | -3.0 |  |
 | 42 | ChemoCentryx Inc. |  | 106.59% | 71.0 |  |
![]() | 43 | JUNIPER PHARMACEUTICALS INC |  | 101.57% | -21.0 |  |
 | 44 | RELIV INTERNATIONAL INC |  | 95.02% | -3.0 |  |
 | 45 | PERRIGO Co plc |  | 93.09% | 71.0 |  |
![]() | 46 | Allergan plc |  | 86.57% | -22.0 |  |
 | 47 | VERU INC. |  | 85.12% | -30.0 |  |
 | 48 | ABEONA THERAPEUTICS INC. |  | 81.30% | 13.0 |  |
 | 49 | PHIBRO ANIMAL HEALTH CORP |  | 80.59% | -1.0 |  |
![]() | 50 | CELGENE CORP DE |  | 80.07% | 0.0 |  |
 | 51 | BIOMARIN PHARMACEUTICAL INC |  | 78.72% | 56.0 |  |
 | 52 | DURECT CORP |  | 75.47% | 159.0 |  |
 | 53 | Zoetis Inc. |  | 73.54% | -4.0 |  |
 | 54 | Sarepta Therapeutics Inc. |  | 72.46% | 129.0 |  |
 | 55 | BRISTOL MYERS SQUIBB CO |  | 63.31% | -27.0 |  |
 | 56 | CUMBERLAND PHARMACEUTICALS INC |  | 61.42% | -26.0 |  |
 | 57 | JOHNSON & JOHNSON |  | 58.88% | 0.0 |  |
 | 58 | Lifevantage Corp |  | 58.79% | -16.0 |  |
 | 59 | Vanda Pharmaceuticals Inc. |  | 58.07% | -5.0 |  |
 | 60 | ANI PHARMACEUTICALS INC |  | 57.85% | -17.0 |  |
 | 61 | NATURES SUNSHINE PRODUCTS INC |  | 57.56% | -26.0 |  |
![]() | 62 | Assertio Therapeutics Inc |  | 57.03% | -25.0 |  |
![]() | 63 | AKORN INC |  | 55.62% | -27.0 |  |
 | 64 | BeiGene Ltd. |  | 53.27% | 29.0 |  |
 | 65 | OPKO HEALTH INC. |  | 53.21% | -33.0 |  |
![]() | 66 | MyoKardia Inc. |  | 48.74% | -22.0 |  |
 | 67 | Bausch Health Companies Inc. |  | 48.46% | 0.0 |  |
 | 68 | LANNETT CO INC |  | 46.50% | -16.0 |  |
 | 69 | Xencor Inc |  | 44.51% | -46.0 |  |
 | 70 | Calithera Biosciences Inc. |  | 44.20% | 130.0 |  |
 | 71 | Intra-Cellular Therapies Inc. |  | 41.73% | 111.0 |  |
 | 72 | IONIS PHARMACEUTICALS INC |  | 36.91% | 13.0 |  |
 | 73 | Blueprint Medicines Corp |  | 36.45% | 3.0 |  |
 | 74 | Endo International plc |  | 34.41% | 1.0 |  |
 | 75 | CATALYST PHARMACEUTICALS INC. |  | 31.86% | 60.0 |  |
 | 76 | ELI LILLY & Co |  | 31.57% | -31.0 |  |
![]() | 77 | Health-Right Discoveries Inc. |  | 26.36% | 166.0 |  |
 | 78 | Travere Therapeutics Inc. |  | 21.10% | -22.0 |  |
 | 79 | SPECTRUM PHARMACEUTICALS INC |  | 16.58% | -6.0 |  |
 | 80 | INTEGRATED BIOPHARMA INC |  | 16.54% | 3.0 |  |
 | 81 | Brooklyn ImmunoTherapeutics Inc. |  | 14.23% | 15.0 |  |
 | 82 | Minerva Neurosciences Inc. |  | 14.23% | -1.0 |  |
 | 83 | Savara Inc |  | 13.41% | 205.0 |  |
 | 84 | Xenetic Biosciences Inc. |  | 9.45% | 0.0 |  |
![]() | 85 | ACHILLION PHARMACEUTICALS INC |  | 5.60% | -45.0 |  |
 | 86 | GERON CORP |  | 0.90% | -22.0 |  |
 | 87 | ALNYLAM PHARMACEUTICALS INC. |  | -4.67% | 30.0 |  |
 | 88 | GLYCOMIMETICS INC | | -5.02% | 122.0 |  |
 | 89 | VBI Vaccines Inc BC | | -7.23% | -11.0 |  |
![]() | 90 | Teligent Inc. | | -7.93% | -22.0 |  |
 | 91 | MEDICINOVA INC | | -11.67% | -9.0 |  |
 | 92 | CV Sciences Inc. | | -12.83% | 116.0 |  |
 | 93 | Protagonist Therapeutics Inc | | -16.31% | 0.0 |  |
 | 94 | OptiNose Inc. | | -17.45% | 0.0 |  |
![]() | 95 | ULURU Inc. | | -20.82% | 144.0 |  |
![]() | 96 | Molecular Templates Inc. | | -21.02% | 154.0 |  |
 | 97 | Histogen Inc. | | -21.07% | 32.0 |  |
 | 98 | Aclaris Therapeutics Inc. | | -23.20% | -21.0 |  |
 | 99 | CytomX Therapeutics Inc. | | -27.08% | 19.0 |  |
![]() | 100 | CymaBay Therapeutics Inc. | | -29.99% | 0.0 |  |
![]() | 101 | Loxo Oncology Inc. | | -31.89% | 0.0 |  |
 | 102 | CHINOOK THERAPEUTICS INC. | | -32.01% | -12.0 |  |
![]() | 103 | ZOGENIX INC. | | -35.83% | -11.0 |  |
 | 104 | CHIMERIX INC | | -36.41% | -30.0 |  |
![]() | 105 | ARENA PHARMACEUTICALS INC | | -37.09% | -39.0 |  |
 | 106 | Apellis Pharmaceuticals Inc. | | -40.17% | 0.0 |  |
 | 107 | MARINUS PHARMACEUTICALS INC. | | -41.40% | 128.0 |  |
 | 108 | Enveric Biosciences Inc. | | -46.15% | 0.0 |  |
![]() | 109 | VIVUS INC | | -49.74% | -52.0 |  |
 | 110 | Sonnet BioTherapeutics Holdings Inc. | | -58.09% | 34.0 |  |
 | 111 | Ainos Inc. | | -59.01% | 112.0 |  |
 | 112 | Avid Bioservices Inc. | | -59.24% | 53.0 |  |
 | 113 | PROTHENA CORP PUBLIC LTD CO | | -59.52% | 1.0 |  |
 | 114 | Akebia Therapeutics Inc. | | -59.69% | 43.0 |  |
 | 115 | Mersana Therapeutics Inc. | | -59.95% | 0.0 |  |
 | 116 | NEKTAR THERAPEUTICS | | -63.54% | 4.0 |  |
 | 117 | IntelGenx Technologies Corp. | | -65.88% | -47.0 |  |
 | 118 | PIERIS PHARMACEUTICALS INC. | | -66.71% | 73.0 |  |
 | 119 | ALBIREO PHARMA INC. | | -69.83% | -8.0 |  |
![]() | 120 | IMMUNE DESIGN CORP. | | -70.44% | 33.0 |  |
 | 121 | ORAMED PHARMACEUTICALS INC. | | -71.45% | -20.0 |  |
 | 122 | Qualigen Therapeutics Inc. | | -76.65% | 172.0 |  |
 | 123 | ARROWHEAD PHARMACEUTICALS INC. | | -79.54% | 62.0 |  |
 | 124 | CHINA PHARMA HOLDINGS INC. | | -80.40% | 0.0 |  |
![]() | 125 | Pfenex Inc. | | -80.65% | -105.0 |  |
 | 126 | Orgenesis Inc. | | -81.82% | -11.0 |  |
![]() | 127 | Dova Pharmaceuticals Inc. | | -82.56% | 0.0 |  |
 | 128 | ROCKET PHARMACEUTICALS INC. | | -86.19% | -7.0 |  |
![]() | 129 | Flexion Therapeutics Inc | | -87.59% | -24.0 |  |
 | 130 | ALIMERA SCIENCES INC | | -95.21% | 24.0 |  |
 | 131 | Arbutus Biopharma Corp | | -97.31% | 145.0 |  |
![]() | 132 | Societal CDMO Inc. | | -99.88% | -48.0 |  |
![]() | 133 | Kura Oncology Inc. | | -100.28% | -6.0 |  |
 | 134 | Sesen Bio Inc. | | -101.34% | -122.0 |  |
![]() | 135 | ARATANA THERAPEUTICS INC. | | -104.19% | -49.0 |  |
![]() | 136 | Old API Wind-down Ltd. | | -105.94% | -34.0 |  |
 | 137 | Cryoport Inc. | | -109.49% | 144.0 |  |
 | 138 | LEXICON PHARMACEUTICALS INC. | | -113.69% | 0.0 |  |
![]() | 139 | SOPHIRIS BIO INC. | | -115.47% | -6.0 |  |
![]() | 140 | NANOVIRICIDES INC. | | -115.68% | -32.0 |  |
![]() | 141 | ARTELO BIOSCIENCES INC. | | -116.94% | 151.0 |  |
![]() | 142 | PROGENICS PHARMACEUTICALS INC | | -120.12% | 0.0 |  |
 | 143 | Revance Therapeutics Inc. | | -120.14% | -3.0 |  |
 | 144 | ARDELYX INC. | | -122.30% | 24.0 |  |
 | 145 | SYNLOGIC INC. | | -123.13% | -19.0 |  |
![]() | 146 | MELINTA THERAPEUTICS INC. NEW | | -128.62% | 0.0 |  |
 | 147 | uniQure N.V. | | -132.09% | -8.0 |  |
![]() | 148 | Citius Pharmaceuticals Inc. | | -134.06% | -23.0 |  |
 | 149 | Spero Therapeutics Inc. | | -134.28% | 0.0 |  |
 | 150 | ImmunoGen Inc. | | -134.87% | 10.0 |  |
 | 151 | DYNAVAX TECHNOLOGIES CORP | | -135.50% | 104.0 |  |
![]() | 152 | AILERON THERAPEUTICS INC | | -136.38% | 0.0 |  |
![]() | 153 | AKCEA THERAPEUTICS INC. | | -139.04% | 0.0 |  |
 | 154 | MusclePharm Corp | | -142.98% | -56.0 |  |
 | 155 | ROCKWELL MEDICAL INC. | | -143.93% | -84.0 |  |
![]() | 156 | FIVE PRIME THERAPEUTICS INC. | | -146.02% | -109.0 |  |
![]() | 157 | REGENERX BIOPHARMACEUTICALS INC | | -147.24% | -15.0 |  |
 | 158 | VYNE Therapeutics Inc. | | -148.76% | 0.0 |  |
 | 159 | Mirati Therapeutics Inc. | | -150.04% | 112.0 |  |
 | 160 | EXICURE INC. | | -150.89% | 0.0 |  |
![]() | 161 | Myovant Sciences Ltd. | | -152.15% | 0.0 |  |
 | 162 | Neoleukin Therapeutics Inc. | | -155.65% | -95.0 |  |
 | 163 | Syndax Pharmaceuticals Inc | | -155.85% | -29.0 |  |
 | 164 | Celsion CORP | | -156.54% | 0.0 |  |
 | 165 | AMICUS THERAPEUTICS INC. | | -157.45% | -107.0 |  |
![]() | 166 | OncoMed Pharmaceuticals Inc | | -157.47% | 5.0 |  |
 | 167 | Epizyme Inc. | | -161.78% | -30.0 |  |
 | 168 | Zynerba Pharmaceuticals Inc. | | -163.11% | 21.0 |  |
 | 169 | SIGA TECHNOLOGIES INC | | -164.11% | -20.0 |  |
 | 170 | OMEROS CORP | | -165.61% | 77.0 |  |
 | 171 | CYTOKINETICS INC | | -165.74% | -142.0 |  |
![]() | 172 | ARRAY BIOPHARMA INC | | -168.89% | 1.0 |  |
 | 173 | iBio Inc. | | -176.59% | -79.0 |  |
 | 174 | Corbus Pharmaceuticals Holdings Inc. | | -178.73% | 78.0 |  |
 | 175 | AMARIN CORP PLC\UK | | -178.80% | -6.0 |  |
 | 176 | Aeglea BioTherapeutics Inc. | | -179.26% | -79.0 |  |
 | 177 | Clovis Oncology Inc. | | -179.72% | 42.0 |  |
![]() | 178 | MUSTANG BIO INC. | | -182.31% | -28.0 |  |
 | 179 | Seres Therapeutics Inc. | | -186.03% | -55.0 |  |
![]() | 180 | Larimar Therapeutics Inc. | | -188.48% | -42.0 |  |
![]() | 181 | Dicerna Pharmaceuticals Inc | | -188.48% | 0.0 |  |
![]() | 182 | Adamas Pharmaceuticals Inc | | -189.75% | -50.0 |  |
 | 183 | Adamis Pharmaceuticals Corp | | -190.29% | -19.0 |  |
 | 184 | Moleculin Biotech Inc. | | -192.04% | -115.0 |  |
![]() | 185 | PORTOLA PHARMACEUTICALS INC | | -195.74% | 22.0 |  |
![]() | 186 | Impax Laboratories LLC | | -195.87% | -74.0 |  |
 | 187 | Jaguar Health Inc. | | -200.59% | 106.0 |  |
 | 188 | HARROW HEALTH INC. | | -202.49% | 4.0 |  |
 | 189 | AGIOS PHARMACEUTICALS INC. | | -203.14% | -86.0 |  |
 | 190 | F-star Therapeutics Inc. | | -212.16% | -4.0 |  |
 | 191 | CNBX Pharmaceuticals Inc. | | -213.01% | 0.0 |  |
 | 192 | XBiotech Inc. | | -213.08% | 30.0 |  |
![]() | 193 | Enochian Biosciences Inc | | -213.77% | 74.0 |  |
 | 194 | PLx Pharma Inc. | | -215.63% | 78.0 |  |
 | 195 | TherapeuticsMD Inc. | | -216.44% | -8.0 |  |
![]() | 196 | Dermira Inc. | | -219.47% | -101.0 |  |
![]() | 197 | Fibrocell Science Inc. | | -220.05% | -21.0 |  |
 | 198 | Paratek Pharmaceuticals Inc. | | -221.45% | 18.0 |  |
 | 199 | SCYNEXIS INC | | -222.49% | -36.0 |  |
 | 200 | CATALYST BIOSCIENCES INC. | | -222.52% | -48.0 |  |
![]() | 201 | ENDOCYTE INC | | -223.64% | -114.0 |  |
 | 202 | COLLEGIUM PHARMACEUTICAL INC | | -226.83% | -25.0 |  |
![]() | 203 | AVENUE THERAPEUTICS INC. | | -227.96% | 0.0 |  |
![]() | 204 | Corium International Inc. | | -229.60% | -32.0 |  |
 | 205 | AGILE THERAPEUTICS INC | | -231.12% | -57.0 |  |
![]() | 206 | BIOVIE INC. | | -231.27% | 0.0 |  |
![]() | 207 | Zyla Life Sciences | | -231.51% | -9.0 |  |
 | 208 | Wave Life Sciences Ltd. | | -232.39% | -99.0 |  |
![]() | 209 | Optec International Inc. | | -234.02% | 0.0 |  |
![]() | 210 | TESARO Inc. | | -236.74% | -59.0 |  |
![]() | 211 | GT Biopharma Inc. | | -237.10% | -210.0 |  |
![]() | 212 | CQENS Technologies Inc. | | -238.72% | 44.0 |  |
 | 213 | Anixa Biosciences Inc | | -239.57% | 0.0 |  |
 | 214 | G1 Therapeutics Inc. | | -241.74% | 0.0 |  |
 | 215 | KalVista Pharmaceuticals Inc. | | -247.74% | 0.0 |  |
![]() | 216 | CARDAX INC. | | -248.90% | 13.0 |  |
 | 217 | NightHawk Biosciences Inc. | | -248.93% | 61.0 |  |
![]() | 218 | PROTEO INC | | -250.93% | -82.0 |  |
![]() | 219 | Neos Therapeutics Inc. | | -251.72% | 5.0 |  |
![]() | 220 | Corvus Pharmaceuticals Inc. | | -253.41% | -148.0 |  |
![]() | 221 | Processa Pharmaceuticals Inc. | | -254.84% | 0.0 |  |
![]() | 222 | SteadyMed Ltd. | | -255.86% | 5.0 |  |
![]() | 223 | ARQULE INC | | -257.56% | -26.0 |  |
 | 224 | Esperion Therapeutics Inc. | | -263.80% | -133.0 |  |
 | 225 | YUMANITY THERAPEUTICS INC. | | -275.98% | -95.0 |  |
![]() | 226 | Achaogen Inc. | | -278.31% | -79.0 |  |
![]() | 227 | Aimmune Therapeutics Inc. | | -286.16% | 0.0 |  |
 | 228 | SELLAS Life Sciences Group Inc. | | -289.82% | -97.0 |  |
![]() | 229 | KEMPHARM INC | | -294.80% | -106.0 |  |
 | 230 | Theravance Biopharma Inc. | | -294.86% | -142.0 |  |
 | 231 | BELLICUM PHARMACEUTICALS INC | | -299.89% | -64.0 |  |
![]() | 232 | Oncternal Therapeutics Inc. | | -300.66% | -28.0 |  |
 | 233 | Xenon Pharmaceuticals Inc. | | -302.38% | -127.0 |  |
 | 234 | INTERCEPT PHARMACEUTICALS INC. | | -303.49% | -59.0 |  |
 | 235 | Edesa Biotech Inc. | | -305.57% | -113.0 |  |
 | 236 | NovaBay Pharmaceuticals Inc. | | -309.76% | -18.0 |  |
 | 237 | CTI BIOPHARMA CORP | | -313.77% | -35.0 |  |
![]() | 238 | Ra Pharmaceuticals Inc. | | -317.77% | -173.0 |  |
 | 239 | Syros Pharmaceuticals Inc. | | -322.69% | -73.0 |  |
 | 240 | Lexaria Bioscience Corp. | | -324.40% | 47.0 |  |
 | 241 | Karyopharm Therapeutics Inc. | | -329.82% | 0.0 |  |
 | 242 | INFINITY PHARMACEUTICALS INC. | | -330.91% | -153.0 |  |
 | 243 | Altimmune Inc. | | -333.04% | -240.0 |  |
 | 244 | Tempest Therapeutics Inc. | | -334.52% | -49.0 |  |
 | 245 | OTONOMY INC. | | -339.97% | -75.0 |  |
 | 246 | SOLIGENIX INC. | | -345.32% | -136.0 |  |
 | 247 | Verastem Inc. | | -347.65% | 0.0 |  |
![]() | 248 | Spotlight Innovation Inc. | | -352.38% | 0.0 |  |
 | 249 | Guardion Health Sciences Inc. | | -355.31% | 62.0 |  |
![]() | 250 | Hepion Pharmaceuticals Inc. | | -364.43% | 0.0 |  |
![]() | 251 | Axsome Therapeutics Inc. | | -364.46% | -55.0 |  |
 | 252 | KIORA PHARMACEUTICALS INC | | -365.25% | 2.0 |  |
![]() | 253 | Synthetic Biologics Inc. | | -367.79% | -5.0 |  |
![]() | 254 | MANNKIND CORP | | -371.24% | -229.0 |  |
 | 255 | ACADIA PHARMACEUTICALS INC | | -372.21% | -99.0 |  |
![]() | 256 | Sio Gene Therapies Inc. | | -372.58% | -7.0 |  |
![]() | 257 | NANOMIX Corp | | -376.28% | 9.0 |  |
 | 258 | International Stem Cell CORP | | -383.57% | -178.0 |  |
![]() | 259 | Nabriva Therapeutics plc | | -386.59% | -80.0 |  |
![]() | 260 | Neurotrope Inc. | | -387.09% | -102.0 |  |
 | 261 | HERON THERAPEUTICS INC. DE | | -389.67% | 24.0 |  |
 | 262 | Lipocine Inc. | | -406.09% | -61.0 |  |
![]() | 263 | Tonix Pharmaceuticals Holding Corp. | | -406.29% | 20.0 |  |
 | 264 | BIO-PATH HOLDINGS INC | | -407.08% | -90.0 |  |
![]() | 265 | KERYX BIOPHARMACEUTICALS INC | | -409.36% | -27.0 |  |
 | 266 | Adhera Therapeutics Inc. | | -415.42% | 0.0 |  |
 | 267 | Regulus Therapeutics Inc. | | -420.62% | -52.0 |  |
 | 268 | CEN BIOTECH INC | | -421.43% | -43.0 |  |
![]() | 269 | PEAK PHARMACEUTICALS INC. | | -422.75% | 0.0 |  |
 | 270 | Ocuphire Pharma Inc. | | -423.29% | -127.0 |  |
![]() | 271 | Strongbridge Biopharma plc | | -431.23% | 0.0 |  |
 | 272 | AVEO PHARMACEUTICALS INC. | | -437.61% | -52.0 |  |
![]() | 273 | Viking Therapeutics Inc. | | -446.81% | -31.0 |  |
![]() | 274 | AXIM BIOTECHNOLOGIES INC. | | -446.83% | 0.0 |  |
![]() | 275 | United Cannabis Corp | | -452.58% | 34.0 |  |
 | 276 | TREVENA INC | | -452.60% | -43.0 |  |
 | 277 | Biohaven Pharmaceutical Holding Co Ltd. | | -458.85% | 0.0 |  |
 | 278 | LEAP THERAPEUTICS INC. | | -466.33% | 0.0 |  |
 | 279 | Advaxis Inc. | | -480.61% | -134.0 |  |
 | 280 | Aravive Inc. | | -483.35% | -125.0 |  |
![]() | 281 | NORTHWEST BIOTHERAPEUTICS INC | | -487.84% | -30.0 |  |
 | 282 | EYENOVIA INC. | | -491.55% | 0.0 |  |
 | 283 | ORAGENICS INC | | -502.43% | 6.0 |  |
 | 284 | Viracta Therapeutics Inc. | | -510.97% | -52.0 |  |
 | 285 | ABVC BIOPHARMA INC. | | -523.40% | 13.0 |  |
 | 286 | Salarius Pharmaceuticals Inc. | | -527.32% | 0.0 |  |
![]() | 287 | ALDER BIOPHARMACEUTICALS INC | | -529.51% | -168.0 |  |
 | 288 | Statera Biopharma Inc. | | -530.59% | -228.0 |  |
 | 289 | Innovation1 Biotech Inc. | | -533.30% | 0.0 |  |
 | 290 | OCULAR THERAPEUTIX INC | | -539.63% | -109.0 |  |
![]() | 291 | ATOSSA THERAPEUTICS INC. | | -539.86% | 0.0 |  |
 | 292 | Checkpoint Therapeutics Inc. | | -543.63% | -108.0 |  |
 | 293 | NEUROPATHIX INC. | | -550.72% | -24.0 |  |
![]() | 294 | Kaya Holdings Inc. | | -556.43% | -8.0 |  |
 | 295 | Matinas BioPharma Holdings Inc. | | -562.88% | -83.0 |  |
 | 296 | Pulmatrix Inc. | | -569.75% | -16.0 |  |
![]() | 297 | Cellectar Biosciences Inc. | | -576.88% | -169.0 |  |
![]() | 298 | ENDONOVO THERAPEUTICS INC. | | -579.44% | 0.0 |  |
![]() | 299 | Bellerophon Therapeutics Inc. | | -591.55% | -86.0 |  |
![]() | 300 | Kintara Therapeutics Inc. | | -595.38% | 0.0 |  |
![]() | 301 | NEXUS BIOPHARMA INC | | -595.41% | 0.0 |  |
![]() | 302 | Cell Source Inc. | | -623.70% | 0.0 |  |
![]() | 303 | CohBar Inc. | | -624.13% | -113.0 |  |
 | 304 | Emmaus Life Sciences Inc. | | -624.63% | -3.0 |  |
 | 305 | CASSAVA SCIENCES INC | | -630.11% | -84.0 |  |
![]() | 306 | Capstone Therapeutics Corp. | | -635.55% | -32.0 |  |
 | 307 | TG THERAPEUTICS INC. | | -637.58% | -32.0 |  |
 | 308 | vTv Therapeutics Inc. | | -645.36% | -64.0 |  |
 | 309 | Innovation Pharmaceuticals Inc. | | -657.12% | -64.0 |  |
 | 310 | AYTU BIOPHARMA INC | | -669.18% | -57.0 |  |
 | 311 | Novan Inc. | | -688.60% | -54.0 |  |
![]() | 312 | SANGUI BIOTECH INTERNATIONAL INC | | -702.03% | 0.0 |  |
![]() | 313 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | | -717.67% | -6.0 |  |
 | 314 | Clearside Biomedical Inc. | | -724.76% | -215.0 |  |
![]() | 315 | TYME TECHNOLOGIES INC. | | -763.33% | 0.0 |  |
![]() | 316 | Ampio Pharmaceuticals Inc. | | -766.21% | -46.0 |  |
![]() | 317 | NeuroBo Pharmaceuticals Inc. | | -770.42% | -137.0 |  |
![]() | 318 | Immune Therapeutics Inc. | | -773.02% | -14.0 |  |
 | 319 | ATHERSYS INC NEW | | -780.69% | -56.0 |  |
 | 320 | Actinium Pharmaceuticals Inc. | | -808.26% | -61.0 |  |
 | 321 | PUMA BIOTECHNOLOGY INC. | | -811.30% | -60.0 |  |
![]() | 322 | Regen BioPharma Inc | | -816.32% | -12.0 |  |
 | 323 | Astria Therapeutics Inc. | | -817.65% | -89.0 |  |
![]() | 324 | HypGen Inc | | -860.31% | -24.0 |  |
![]() | 325 | Oncolix Inc. | | -902.43% | -12.0 |  |
![]() | 326 | MABVAX THERAPEUTICS HOLDINGS INC. | | -923.76% | -58.0 |  |
![]() | 327 | RespireRx Pharmaceuticals Inc. | | -936.34% | -31.0 |  |
 | 328 | Onconova Therapeutics Inc. | | -1053.76% | -119.0 |  |
 | 329 | Monopar Therapeutics | | -1105.74% | 0.0 |  |
![]() | 330 | ImmunoCellular Therapeutics Ltd. | | -1131.13% | -70.0 |  |
![]() | 331 | RELMADA THERAPEUTICS INC. | | -1135.24% | -227.0 |  |
![]() | 332 | Rezolute Inc. | | -1146.04% | -55.0 |  |
 | 333 | VistaGen Therapeutics Inc. | | -1203.18% | -21.0 |  |
![]() | 334 | Marker Therapeutics Inc. | | -1210.36% | 0.0 |  |
![]() | 335 | Genprex Inc. | | -1242.19% | 0.0 |  |
 | 336 | CorMedix Inc. | | -1278.98% | -72.0 |  |
![]() | 337 | Greater Cannabis Company Inc. | | -1287.34% | 0.0 |  |
![]() | 338 | Evofem Biosciences Inc. | | -1359.51% | -80.0 |  |
![]() | 339 | Propanc Biopharma Inc. | | -1366.58% | -33.0 |  |
![]() | 340 | Skye Bioscience Inc. | | -1404.32% | -45.0 |  |
 | 341 | GeoVax Labs Inc. | | -1408.20% | -33.0 |  |
![]() | 342 | EnzymeBioSystems | | -1426.11% | 0.0 |  |
 | 343 | Phio Pharmaceuticals Corp. | | -1525.66% | -149.0 |  |
![]() | 344 | ProtoKinetix Inc. | | -1730.74% | -41.0 |  |
![]() | 345 | Anthera Pharmaceuticals Inc | | -1793.52% | -55.0 |  |
 | 346 | 9 METERS BIOPHARMA INC. | | -2064.67% | -116.0 |  |
![]() | 347 | GlobeStar Therapeutics Corp | | -2230.43% | 0.0 |  |
![]() | 348 | Wellness Center USA Inc. | | -3087.98% | 0.0 |  |
![]() | 349 | Q BioMed Inc. | | -9034.32% | -58.0 |  |